Copenhagen Prospective Personalized Oncology (CoPPO)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUlrik Lassen
About this trial
Patients with advanced solid tumors referred to the Phase 1 Unit are offered mapping of GA for identification of pts who could benefit from a personalized treatment.
Eligibility criteria
Qualifiers
Solid tumor
No standard treatment option
PS 0-1
Lesion assessable for biopsy
Disqualifiers
Life expectancy < 3 months
Bone marrow suppression
Abnormal renal or hepatic function
Serious concurrent medical conditions
Trial design
Treatments tested in this trial
- Tumor biopsy
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Ulrik Lassen
Lead sponsor
Rigshospitalet, Denmark
Sponsor institution
Source ClinicalTrials.gov